Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

MEK1/2 inhibition attenuates vascular ETA and ETB receptor alterations after cerebral ischaemia

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Sensory defunctionalization induced by 8% topical capsaicin treatment in a model of ultraviolet-B-induced cutaneous hyperalgesia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Influence of visual feedback, hand dominance and sex on individuated finger movements

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Improved assessment of outcomes following transient global cerebral ischemia in mice

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Effects of dopaminergic treatment on functional cortico-cortical connectivity in Parkinson's disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Cue integration and the perception of action in intentional binding

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Hormonal influences in migraine - interactions of oestrogen, oxytocin and CGRP

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. CGRP and migraine; from bench to bedside

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Cerebral ischaemia is associated with elevated levels of endothelin B (ETB) receptors in the ipsilateral middle cerebral artery (MCA). This up-regulation of ET receptors occurs via de novo transcription involving mitogen-activated protein kinases (MAPK). The aim of this study was to examine the effect of inhibition of the MAP kinase/ERK kinase (MEK)1/2 on ET receptor alteration, brain damage, and neurology in experimental cerebral ischaemia. Transient middle cerebral artery occlusion (MCAO) was induced in male Wistar rats by the intraluminal filament technique. The animals received 100 mg/kg intraperitoneally of the MEK1/2 inhibitor U0126 or vehicle in conjunction with the occlusion. After 24 h, the rats were decapitated and the brains removed. The middle cerebral arteries were dissected out and examined with myographs or immunohistochemistry. The ischaemic areas of the brains were compared. After the MCAO, the contractile responses of the ETA and ETB receptors were augmented in the ipsilateral MCA. U0126 decreased this alteration in ET receptor response. Furthermore, treatment with U0126 significantly decreased the brain damage and improved neurological scores. Immunohistochemistry showed that there were lower protein levels of phosphorylated extracellular signal-regulated kinases (ERK)1/2 and phosphorylated transcription factor Elk-1 in the U0126-treated rats compared to control. The results show that treatment with the MEK1/2 inhibitor U0126 in ischaemic stroke decreases brain damage, neurological symptoms, and ET receptor alteration. The vascular effects of U0126 provide new perspective on possible mechanisms of actions of MAPK inhibition in cerebral ischaemia.

OriginalsprogEngelsk
TidsskriftExperimental Brain Research
Vol/bind178
Udgave nummer4
Sider (fra-til)470-6
Antal sider7
ISSN0014-4819
DOI
StatusUdgivet - apr. 2007
Eksternt udgivetJa

ID: 44883313